Novotech White Papers

31. The Immuno-Oncology Clinical Trial Landscape In The Asia Pacific 9/22/2022

    Learn how the Asia Pacific has shown significant increase in Immuno-oncology (IO) trials between 2017 and 2021 and contributes to about 35% of clinical development in IO globally. 

32. Clinical Development Strategies For Western Biotech Companies In China 9/22/2022

    Delve into how China is now more aligned with international standards, enabling biotech firms to streamline processes and timelines, which has significantly recharged biotech innovation.

33. Evolution Of Clinical Trials In The Asia Pacific Region 9/22/2022

    With changing global clinical trials landscape, explore how APAC is emerging as the hot spot for conducting clinical trials, especially in China.